42 /100
MEDIUM RISK
Score updated Jul 13, 2026

DBVTF — DBV TECHNOLOGIES Dilution Risk Tracker

Track DBVTF dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track DBVTF — Get alerts when the score changes →

As of July 13, 2026, DBV TECHNOLOGIES (DBVTF) has a DilutionWatch DilutionScore of 42/100, rated MEDIUM dilution risk. DBV TECHNOLOGIES has a market capitalization of $1.26B, 296.04M shares outstanding, 72 institutional holders tracked. Key dilution vectors include approximately 22 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
25
📊 Float Risk
29
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for DBVTF.
🔔 Track DBVTF — Get forecast alerts →

💹 Market Data

Market Cap$1.26B
Shares Outstanding296.04M
Float176.27M
Cash$229.20M
Debt$1.46M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 54.4% shares (2026Q1 vs prior)
72 institutional holders · 24.98M shares
#1 Vivo Capital, LLC 5.34M shares
#2 MPM BIOIMPACT LLC 5.21M shares
#3 Artisan Partners Limited Partnership 2.22M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest37.4K
Days to Cover1000.0
% of Float0.0%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for DBVTF Shareholders

DBV TECHNOLOGIES (DBVTF) has a DilutionScore of 42/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 13, 2026.

DilutionWatch's EDGAR monitoring for DBVTF shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for DBVTF in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for DBVTF alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track DBVTF Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking DBVTF — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for DBVTF
📊 DBVTF FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 DBVTF Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.